Entering text into the input field will update the search result below

Insys Therapeutics beats by $0.02, beats on revenue

  • Insys Therapeutics (INSY): Q3 EPS of $0.31 beats by $0.02; Non-GAAP EPS of $0.63.
  • Revenue of $58.28M (+99.5% Y/Y) beats by $1.2M.
  • Press Release

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
INSYQ--
INSYS Therapeutics, Inc.